Magnetic resonance imaging (MRI) is a clinical imaging technique that allows for non-invasive visualization inside the human body with excellent soft tissue contrast with a sub-millimeter resolution. Qualitative MRI is used to visually highlight normal or pathological components by exploiting the physical properties of different tissues. However, these acquisitions provide minimal consistency between scans, patients, and scanners. To address this issue, quantitative MRI (qMRI) provides absolute measures that give meaningful physical information about tissues, enabling objective comparisons. Relaxometry, a branch of qMRI that characterizes tissues through their magnetic relaxation properties, has been employed to quantitatively assess various diseases with different biomarkers in the past. However, certain radiofrequency (RF) pulses used to induce relaxation times weighting in the MRI signal are sensitive to field inhomogeneities, which makes consistent quantification of relaxation times difficult. In order to improve sensitivity and detect more diseases, better contrast mechanisms and biomarkers are crucial. One promising technique is Relaxation Along a Fictitious Field (RAFF), which may serve as a biomarker for a wide range of diseases due to its sensitivity to slow molecular motion in tissue. Currently, it has the downside of being sensitive to off-resonance and B1+ artifacts, which hampers clinical application. This project aims to develop novel contrasts for quantitative MRI by investigating the performance of adapted RF pulses. Ultimately, the goal is to reduce the susceptibility to off-resonance and B1+ artifacts for the RF pulses.